Get complete Patent Opposition Report for Teva Pharmaceutical Industries

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Teva Pharmaceutical Industries against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3582814Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025
EP3529360Methods For Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (Pcsk9) Protein ReductionNOVARTISJan 17, 2025
EP3565542Polymorphic Forms Of Rad1901-2HclRADIUS PHARMACEUTICALSJan 10, 2025
EP3328416Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 12, 2024
EP4159204Novel Pharmaceutical CompositionNOVARTISNov 13, 2024
EP4159205Novel Pharmaceutical CompositionNOVARTISNov 13, 2024
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 12, 2024
EP2395968Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIMOct 16, 2024
EP3478286Methods Of Treating Ovarian CancerTESAROOct 1, 2024
EP3634380Inhibition Of Crystal Growth Of RoflumilastARCUTISSep 20, 2024

Explore Teva Pharmaceutical Industries's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3554581Mar 13, 2024Medical Injection Device Packaging4
EP3050556Mar 22, 2017Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate2